| HCPCS Code | Code Dosage | Payment Limit |
Vaccine AWP % | Vaccine Limit | Infusion AWP % | DME infusion limit | Blood AWP % | Blood limit | Clotting factor | Note |
|---|---|---|---|---|---|---|---|---|---|---|
J9045 - Injection, carboplatin, 50 mg |
50 MG | 2.608 | - | - | - | - | - | - | ||
J9047 - Injection, carfilzomib, 1 mg |
1 MG | 41.111 | - | - | - | - | - | - | ||
J9050 - Injection, carmustine, 100 mg |
100 MG | 1099.822 | - | - | - | - | - | - | ||
J9055 - Injection, cetuximab, 10 mg |
10 MG | 67.618 | - | - | - | - | - | - | ||
J9060 - Injection, cisplatin, powder or solution, 10 mg |
10 MG | 1.864 | - | - | - | - | - | - | ||
J9061 - Injection, amivantamab-vmjw, 2 mg |
2 MG | 17.905 | - | - | - | - | - | - | ||
J9065 - Injection, cladribine, per 1 mg |
1 MG | 15.084 | - | - | - | - | - | - | ||
J9070 - Cyclophosphamide, 100 mg |
100 MG | 27.473 | - | - | - | - | - | - | ||
J9100 - Injection, cytarabine, 100 mg |
100 MG | 0.881 | - | - | - | - | - | - | ||
J9119 - Injection, cemiplimab-rwlc, 1 mg |
1 MG | 27.674 | - | - | - | - | - | - | ||
J9120 - Injection, dactinomycin, 0.5 mg |
0.5 MG | 838.879 | - | - | - | - | - | - | ||
J9130 - Dacarbazine, 100 mg |
100 MG | 3.616 | - | - | - | - | - | - | ||
J9144 - Injection, daratumumab, 10 mg and hyaluronidase-fihj |
10 MG | 45.034 | - | - | - | - | - | - | ||
J9145 - Injection, daratumumab, 10 mg |
10 MG | 57.222 | - | - | - | - | - | - | ||
J9150 - Injection, daunorubicin, 10 mg |
10 MG | 41.236 | - | - | - | - | - | - | ||
J9153 - Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine |
1 MG/2.27 MG | 207.631 | - | - | - | - | - | - | ||
J9155 - Injection, degarelix, 1 mg |
1 MG | 4.061 | - | - | - | - | - | - | ||
J9171 - Injection, docetaxel, 1 mg |
1 MG | 0.459 | - | - | - | - | - | - | ||
J9173 - Injection, durvalumab, 10 mg |
10 MG | 76.859 | - | - | - | - | - | - | ||
J9176 - Injection, elotuzumab, 1 mg |
1 MG | 6.86 | - | - | - | - | - | - | ||
J9177 - Injection, enfortumab vedotin-ejfv, 0.25 mg |
0.25 MG | 30.186 | - | - | - | - | - | - | ||
J9178 - Injection, epirubicin hcl, 2 mg |
2 MG | 1.455 | - | - | - | - | - | - | ||
J9179 - Injection, eribulin mesylate, 0.1 mg |
0.1 MG | 127.436 | - | - | - | - | - | - | ||
J9181 - Injection, etoposide, 10 mg |
10 MG | 0.758 | - | - | - | - | - | - | ||
J9185 - Injection, fludarabine phosphate, 50 mg |
50 MG | 57.02 | - | - | - | - | - | - | ||
| * Effective January 1, 2022 through March 31, 2022 | ||||||||||
Medicare Part B payment allowance limits for drugs not otherwise classified - Effective January 1, 2022 through March 31, 2022
| Drug name | Dosage | Payment limit | Notes |
|---|---|---|---|
| Alfentanil Hcl | 500 MCG | 1.973 | |
| Allopurinol Sodium | 500 MG | 3175.581 | |
| Aminocaproic acid | 250 MG | 0.303 | |
| Aztreonam | 500 MG | 14.07 | |
| Bumetanide | 0.25 MG | 0.289 | |
| Bupivacaine | 1 ML | 0.107 | |
| Clindamycin Phosphate | 150 MG | 1.054 | |
| Coagulation Factor IX, Recombinant (Ixinity) | 1 IU | 2.274 | includes clotting factor furnishing fee |
| Diltiazem Hydrochloride | 5 MG | 0.287 | |
| Doxycycline Hyclate | 100 MG | 17.547 | |
| Esmolol Hydrochloride | 10 MG | 0.292 | |
| Famotidine | 10 MG | 0.434 | |
| Flumazenil | 0.1 MG | 0.894 | |
| Folic Acid | 5 MG | 2.522 | |
| Glucarpidase | 10 UNITS | 345.308 | |
| Glycopyrrolate injection | 0.2 MG | 2.072 | |
| Immune Globulin (Cutaquig) | 100 MG | 13.526 | |
| Immune Globulin (Panzyga) | 500 MG | 65.046 | |
| Labetalol Hcl | 5 MG | 0.16 | |
| Metoprolol Tartrate | 1 MG | 0.14 | |
| Metronidazole inj | 500 MG | 1.177 | |
| Nitroglycerin | 5 MG | 1.352 | |
| Olanzapine short acting intramuscular injection | 0.5 MG | 1.122 | |
| Paliperidone Palmitate (Invega Trinza) | 1 MG | 10.673 | |
| Rifampin | 600 MG | 98.068 | |
| Sodium Chloride, Hypertonic (3% - 5% infusion) | 250 CC | 1.497 | |
| Sulfamethoxazole-Trimethoprim | 400-80 MG | 0.603 | |
| Vasopressin | 20 UNITS | 219.428 |
Added January 2022